1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

TherapeuticsMD

Anonymous board for TherapeuticsMD


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    5
    Views:
    1,637
  2. anonymous
    Replies:
    12
    Views:
    3,168
  3. anonymous
    Replies:
    1
    Views:
    777
  4. anonymous
    Replies:
    1
    Views:
    701
  5. anonymous
    Replies:
    10
    Views:
    3,905
  6. anonymous
    Replies:
    0
    Views:
    652
  7. anonymous
    Replies:
    8
    Views:
    1,518
  8. anonymous
    Replies:
    0
    Views:
    536
  9. anonymous
    Replies:
    0
    Views:
    866
  10. anonymous
    Replies:
    12
    Views:
    4,257
  11. anonymous
    Replies:
    0
    Views:
    884
  12. anonymous
    Replies:
    0
    Views:
    1,420
  13. anonymous
    Replies:
    0
    Views:
    1,605
  14. anonymous
    Replies:
    6
    Views:
    1,843
  15. anonymous
    Replies:
    0
    Views:
    1,368
  16. anonymous
    Replies:
    6
    Views:
    3,433
  17. anonymous
    Replies:
    5
    Views:
    2,272
  18. anonymous
    Replies:
    0
    Views:
    1,505
  19. anonymous
    Replies:
    2
    Views:
    3,404
  20. Anonymous
    Replies:
    8
    Views:
    7,930

Thread Display Options

Loading...